Bevacizumab for Non Small Cell Lung Cancer User Reviews
Brand names: Avastin, Zirabev, Mvasi, Avzivi, Alymsys, Jobevne, Vegzelma
Are you taking this medicine?
Your review helps others make informed decisions.Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
More about bevacizumab
- Check interactions
- Compare alternatives
- Reviews (37)
- Side effects
- Dosage information
- During pregnancy
- Drug class: VEGF/VEGFR inhibitors
- Breastfeeding
- En español
Patient resources
- Bevacizumab drug information
- Bevacizumab-adcd (Advanced Reading)
- Bevacizumab-awwb (Advanced Reading)
- Bevacizumab-bvzr (Advanced Reading)
- Bevacizumab-maly (Advanced Reading)
Other brands
Avastin, Zirabev, Mvasi, Avzivi, ... +2 more
Professional resources
Other brands
Avastin, Mvasi, Avzivi, Alymsys, Jobevne
"July 31, 2006 diagnosis: stage 4 non-small cell lung cancer. I began with a clinical trial of Avastin in January '07. I continue to have the infusion every three weeks; my cancer is in remission. Normal life expectancy for this stage cancer is 2 to 5 years. God has blessed me so far with 2 1/4 yrs of wonderful life and no reason to think it won't continue much longer than 5. I'm halfway there and God has been so good to make the doctors and medication available to me. I recommend it to anyone. Side effects are minimal for me."